You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK)獲高瓴19.21億港元入股 佔股5%
格隆匯 05-14 13:05

格隆匯5月14日丨金斯瑞生物科技(01548.HK)宣佈,於2021年5月14日,公司與該投資者訂立認購協議,據此,該投資者已同意認購公司將發行的約1.03億股新股份,佔經擴大後總股本約5.00%;認購價每股18.658港元。交易完成後,該投資者預期持有合共約1.03億股股份,佔經擴大後總股本約5.00%。

該投資者乃指GNS Holdings Limited,其為根據開曼羣島法律成立的公司。高瓴資本管理有限公司為該投資者的唯一投資管理人。

認購事項的所得款項總額預期約19.21億港元。公司擬將該等所得款項淨額用作集團的一般營運資金,主要用於研發及擴張生產設施,以及一般公司費用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account